FDA Approves NEXIUM(R) I.V. (Esomeprazole Sodium) For The Treatment Of GERD With Erosive Esophagitis In Pediatric And Adolescent Patients
Friday, Dec. 30th 2011 6:40 AM
AstraZeneca (NYSE: AZN) announced today that the U.S. Food and Drug Administration (FDA) has approved the use of NEXIUM® I.V. (esomeprazole sodium) for Injection for children ages greater than 1 month old for the short-term treatment of gastroesophageal reflux disease (GERD) with erosive esophagitis when oral therapy is not possible or appropriate.1 NEXIUM I.V.
Related posts:
- Share of Cost, Esophageal Cancer Risk Lower Than Expected For GERD Patients Share of Cost, The risk of esophageal cancer among patients who suffer from gastroesophageal reflux disease (GERD) is not as high as many may think, according to new research from University of Michigan gastroenterologists. GERD is considered a relative risk for developing esophageal adenocarcinoma, but the absolute risk is not known, says Joel Rubenstein, M.D., […]...
- California Share of Cost, Weight Loss And Physical Activity Improve Symptoms Of GERD California Share of Cost, Weight Loss And Physical Activity Improve Symptoms Of GERD: Gastroesophageal reflux disease (GERD) is a debilitating problem for sufferers — heartburn, difficulty swallowing, chest pain and acid reflux....
- Share of Cost, For Acid Reflux Disease Patients, Esophageal Cancer Risk Lower Than Expected Share of Cost, The risk of esophageal cancer among patients who suffer from gastroesophageal reflux disease (GERD) is not as high as many may think, according to new research from University of Michigan gastroenterologists. GERD is considered a relative risk for developing esophageal adenocarcinoma, but the absolute risk is not known, says Joel Rubenstein, M.D., […]...
- Share of Cost: Obese Children At Higher Risk Of GERD Share of Cost: Obese Children At Higher Risk Of GERD –A large US study found that compared to normal weight children, obese children have a higher risk of developing gastroesophageal reflux disease (GERD), a condition where stomach fluid flows up into the food pipe or esophagus, damaging the lining and possibly also raising the incidence […]...
- Share of Cost, ASGS Issues Position Statement Supporting Transoral Fundoplication For Select GERD Patients EndoGastric Solutions (EGS), the leader in the emerging field of Natural Orifice Surgery (NOS), today announced that the American Society of General Surgeons (ASGS) recently issued a position statement in support of transoral fundoplication for the surgical treatment of gastroesophageal reflex disease (GERD)....
- New Mexico Share of Cost, Disagreement On Symptom-Reflux Association Analysis Parameters In Infants New Mexico Share of Cost, Disagreement On Symptom-Reflux Association Analysis Parameters In Infants: Gastroesophageal reflux (GER), defined as passage of gastric contents into the esophagus is a normal process that occurs in healthy infants, children and adults. When GER causes troublesome symptoms and/or complications it is referred to as gastroesophageal reflux disease (GERD)....
- Texas Share of Cost, Axanum And Expanded Nexium Indication Rejected By FDA Texas Share of Cost, Axanum And Expanded Nexium Indication Rejected By FDA: The Food and Drug Administration (FDA), USA has denied approval of AstraZeneca’s Axanum (aspirin plus esomeprazole magnesium) and an expanded indication for AstraZeneca’s Nexium (esomeprazole magnesium). AstraZeneca received a CRL (Complete Response Letter) for the new drug application for Axanum tablets, as well […]...
- Patients Living With Gerd Now Have A New Treatment Option For Improved And Sustained Symptom Relief Takeda is pleased to announce that DEXILANT™ (dexlansoprazole) is now available in Canada. DEXILANT is the first and only proton pump inhibitor (PPI) with a novel DUAL DELAYED RELEASE technology, which delivers two separate doses of medication at different times providing improved and sustained symptom relief throughout the day and night....
- Link Between Cough And Reflux Studied With New Sound Recording Device Coughing episodes are closely related to gastroesophageal reflux symptoms in patients who experience chronic cough, irrespective of other diagnoses, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. Gastroesophageal reflux occurs when the acid contents of the stomach back up, or reflux, into the esophagus....
- Stomach Acidity Medications Increase Risk Of Pneumonia Proton pump inhibitors and histamine2 receptor antagonists – types of acid suppressive medications commonly taken to treat the overproduction of gastric acid, such as acid reflux (GERD/GORD), dyspepsia, and peptic ulcer disease may raise the risk of pneumonia, researchers from Seoul National University Hospital, South Korea, report in CMAJ (Canadian Medical Association Journal)....
Posted on Friday, Dec. 30th 2011 6:40 AM | by Share of Cost | in Share of Cost | No Comments »